Hubly Surgical Receives Innovative Technology Contract from Vizient, Inc.

Contract awarded for products that bring improvement to healthcare industry

LISLE, Ill., Sept. 18, 2025 /PRNewswire/ -- Hubly Surgical, a leader in safe neurotechnology and in modernizing bedside intracranial access, announced today that its FDA-cleared Hubly Auto-Stop Drill + Cranial Access Kit has received an Innovative Technology contract from Vizient, Inc., the nation's largest provider-driven healthcare performance improvement company.

The contract was awarded following review of the Hubly Auto-Stop Drill + Cranial Access Kit by hospital experts who serve on one of Vizient's client-led councils. This contract signifies to Vizient clients that the Hubly Drill offers unique qualities with the potential to bring meaningful improvements to patient safety, clinical efficiency, and healthcare worker safety.

Innovative Technology contracts are recommended after review and interaction with products submitted through Vizient's Innovative Technology Program. Vizient's client-led councils identify technologies that can enhance clinical care, improve patient or worker safety, or streamline healthcare operations.

"We are eager to work with Vizient clients to modernize neurosurgery and save lives," said Casey Qadir, CEO of Hubly Surgical. "Securing this contract validates the value our technology brings to patients, physicians, and hospitals and will help accelerate access to hospitals nationwide."

The Hubly Surgical Auto-Stop Drill is built to make delicate brain procedures like EVD placement / ventriculostomy and intracranial pressure monitoring safer, faster, and easier for clinicians to perform in the ICU, right at a patient's bedside. The single-use, cordlessly powered drill has built-in proprietary safety features, including real-time visual force control and 100% effective SMART Auto-Stop that automatically halts drilling upon skull penetration to prevent accidental plunge into the patient's brain. These features are designed to improve patient outcomes and hospital efficiency.

Since its 2024 commercial launch, Hubly Surgical has sold over 6,000 Auto-Stop Drills across the United States. The technology has been adopted by leading health systems for its safety, speed, ease of use, and ability to streamline critical neurosurgical interventions.

"After a review of Hubly Auto-Stop Drill + Cranial Access Kit, Vizient's client-led council agreed this technology offers a unique benefit over other products available in the market today and recommended it for an Innovative Technology contract. We are pleased to award this new contract to Hubly Surgical," said Kelly Flaharty, senior director of contract services for Vizient.

About Vizient

Vizient represents a diverse client base that includes academic medical centers, pediatric facilities, community hospitals, integrated delivery networks, and non-acute healthcare providers. Its portfolio represents more than $156 billion in annual purchasing volume. Through its Innovative Technology Program, Vizient works with client-led councils and task forces to evaluate products for their potential to bring real innovation to healthcare. If a product is determined to be innovative, Vizient may award a contract outside the competitive bid cycle.

About Hubly Surgical
Hubly Surgical is a medical device company committed to advancing patient safety and improving outcomes through innovative surgical technologies. Its flagship product, the Hubly Auto-Stop Drill, incorporates safety features that can help reduce complications in intracranial access. For more information, visit hublysurgical.com.

SOURCE Hubly Surgical Inc.